GB201021390D0 - Treatment of obesity or diabetes with bile acid sequestrants - Google Patents
Treatment of obesity or diabetes with bile acid sequestrantsInfo
- Publication number
- GB201021390D0 GB201021390D0 GBGB1021390.8A GB201021390A GB201021390D0 GB 201021390 D0 GB201021390 D0 GB 201021390D0 GB 201021390 A GB201021390 A GB 201021390A GB 201021390 D0 GB201021390 D0 GB 201021390D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- obesity
- diabetes
- treatment
- bile acid
- acid sequestrants
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 208000008589 Obesity Diseases 0.000 title 1
- 229920000080 bile acid sequestrant Polymers 0.000 title 1
- 229940096699 bile acid sequestrants Drugs 0.000 title 1
- 206010012601 diabetes mellitus Diseases 0.000 title 1
- 235000020824 obesity Nutrition 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Child & Adolescent Psychology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28813409P | 2009-12-18 | 2009-12-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
GB201021390D0 true GB201021390D0 (en) | 2011-01-26 |
GB2476384A GB2476384A (en) | 2011-06-22 |
Family
ID=43567346
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1021390A Withdrawn GB2476384A (en) | 2009-12-18 | 2010-12-16 | Labile bile acid sequestrant for use in the treatment of obesity or diabetes |
Country Status (3)
Country | Link |
---|---|
US (1) | US20110152204A1 (en) |
GB (1) | GB2476384A (en) |
WO (1) | WO2011075539A2 (en) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2591188C2 (en) | 2010-11-08 | 2016-07-10 | Альбирео Аб | Ibat inhibitor for treating hepatic disorders |
EP3498271A1 (en) * | 2011-05-02 | 2019-06-19 | Biokier, Inc. | Composition and method for treatment of diabetes |
CN107375291A (en) * | 2011-10-28 | 2017-11-24 | 鲁美纳医药公司 | For treating the bile acid recycling inhibitors of high cholemia and cholestatic liver disease |
MX354242B (en) | 2011-10-28 | 2018-02-20 | Lumena Pharmaceuticals Inc | Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases. |
JP2017517550A (en) | 2014-06-13 | 2017-06-29 | ユナイテッド セラピューティクス コーポレイション | Treprostinil preparation |
CA2952406A1 (en) | 2014-06-25 | 2015-12-30 | Ea Pharma Co., Ltd. | Solid formulation and method for preventing or reducing coloration thereof |
US10786529B2 (en) | 2016-02-09 | 2020-09-29 | Albireo Ab | Oral cholestyramine formulation and use thereof |
US10441604B2 (en) | 2016-02-09 | 2019-10-15 | Albireo Ab | Cholestyramine pellets and methods for preparation thereof |
US10441605B2 (en) | 2016-02-09 | 2019-10-15 | Albireo Ab | Oral cholestyramine formulation and use thereof |
CZ201740A3 (en) * | 2017-01-26 | 2018-08-08 | Vidia spol. s r.o. | Use of a preparation for peroral administration containing lignin |
WO2019032026A1 (en) | 2017-08-09 | 2019-02-14 | Albireo Ab | Cholestyramine granules, oral cholestyramine formulations and use thereof |
EP3802504B1 (en) | 2018-06-05 | 2023-01-18 | Albireo AB | Benzothia(di)azepine compounds and their use as bile acid modulators |
US10793534B2 (en) | 2018-06-05 | 2020-10-06 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
US11802115B2 (en) | 2018-06-20 | 2023-10-31 | Albireo Ab | Pharmaceutical formulation of odevixibat |
US11801226B2 (en) | 2018-06-20 | 2023-10-31 | Albireo Ab | Pharmaceutical formulation of odevixibat |
US11007142B2 (en) | 2018-08-09 | 2021-05-18 | Albireo Ab | Oral cholestyramine formulation and use thereof |
US11549878B2 (en) | 2018-08-09 | 2023-01-10 | Albireo Ab | In vitro method for determining the adsorbing capacity of an insoluble adsorbant |
US10722457B2 (en) | 2018-08-09 | 2020-07-28 | Albireo Ab | Oral cholestyramine formulation and use thereof |
US10941127B2 (en) | 2019-02-06 | 2021-03-09 | Albireo Ab | Benzothiadiazepine compounds and their use as bile acid modulators |
US10975045B2 (en) | 2019-02-06 | 2021-04-13 | Aibireo AB | Benzothiazepine compounds and their use as bile acid modulators |
JP2023504647A (en) | 2019-12-04 | 2023-02-06 | アルビレオ・アクチボラグ | Benzothia(di)azepine compounds and their use as bile acid modulators |
US11014898B1 (en) | 2020-12-04 | 2021-05-25 | Albireo Ab | Benzothiazepine compounds and their use as bile acid modulators |
IL293379A (en) | 2019-12-04 | 2022-07-01 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
CA3158181A1 (en) | 2019-12-04 | 2021-06-10 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
JP2023504644A (en) | 2019-12-04 | 2023-02-06 | アルビレオ・アクチボラグ | Benzothiadiazepine compounds and their use as bile acid modulators |
CA3186857A1 (en) | 2020-08-03 | 2022-02-10 | Per-Goran Gillberg | Benzothia(di)azepine compounds and their use as bile acid modulators |
CN111956627B (en) * | 2020-09-25 | 2022-02-18 | 郑州大学 | Preparation method and application of drug compound with nano targeting effect for improving II type diabetes pancreatic microenvironment |
KR20230106651A (en) | 2020-11-12 | 2023-07-13 | 알비레오 에이비 | Odevixivat for the treatment of progressive familial intrahepatic cholestasis (PFIC) |
CN116583504A (en) | 2020-12-04 | 2023-08-11 | 阿尔比里奥公司 | Benzothiazepine compounds and their use as bile acid modulators |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1245890B (en) * | 1991-04-12 | 1994-10-25 | Alfa Wassermann Spa | PHARMACEUTICAL FORMULATIONS FOR ORAL USE GASTRORESANTS CONTAINING BILE ACIDS. |
US5900233A (en) * | 1997-10-16 | 1999-05-04 | Day; Charles E. | Epichlorohydrin and 1-(3-aminopropyl) imidazole copolymer and its use in treating irritable bowel syndrome |
US6309663B1 (en) * | 1999-08-17 | 2001-10-30 | Lipocine Inc. | Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents |
SI1307264T1 (en) * | 2000-07-28 | 2005-02-28 | F. Hoffmann-La Roche Ag | New pharmaceutical composition |
DE60221798T2 (en) * | 2001-01-26 | 2008-06-05 | Schering Corp. | COMBINATIONS OF BALANCED ACID SEQUESTRIAL AGENTS AND INHIBITORS OF STEROL ABSORPTION FOR THE TREATMENT OF CARDIOVASCULAR INDICATIONS |
AU2003222010A1 (en) * | 2002-03-18 | 2003-10-08 | Pharmacia Corporation | Combination of an aldosterone receptor antagonist and a bile acid sequestering agent |
AU2003233653B2 (en) * | 2002-05-23 | 2008-08-07 | Umd, Inc. | Compositions and method for transmucosal drug delivery and cryoprotection |
WO2006014979A2 (en) * | 2004-07-27 | 2006-02-09 | Sukhe International Sdn. Bhd. | Palm fiber-based dietary supplements |
JP2008521800A (en) * | 2004-11-24 | 2008-06-26 | セオ ホン ユー | Dry form of water-solubilized bile acid dosage formulation, production method and use thereof |
US20070025953A1 (en) * | 2005-07-27 | 2007-02-01 | Jones Michael R | Co-therapy for diabetic conditions |
JP2012509892A (en) * | 2008-11-26 | 2012-04-26 | サティオゲン ファーマシューティカルズ,インク. | Compositions containing satiogens and methods of use |
-
2010
- 2010-12-15 WO PCT/US2010/060592 patent/WO2011075539A2/en active Application Filing
- 2010-12-15 US US12/969,388 patent/US20110152204A1/en not_active Abandoned
- 2010-12-16 GB GB1021390A patent/GB2476384A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2011075539A3 (en) | 2011-11-24 |
US20110152204A1 (en) | 2011-06-23 |
GB2476384A (en) | 2011-06-22 |
WO2011075539A2 (en) | 2011-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB201021390D0 (en) | Treatment of obesity or diabetes with bile acid sequestrants | |
GB2465879B (en) | Bile acid recylcing inhibitors for treatment of obesity and diabetes | |
EP2575821A4 (en) | Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions | |
IL259475A (en) | Combination therapy for the treatment of diabetes | |
HUE056278T2 (en) | Obesity treatment | |
GB2472496B (en) | Treatment of titanium ores | |
EP2405869A4 (en) | Obesity treatment | |
GB0915515D0 (en) | Treatment of vasculoproliferative conditions | |
PT2376077T (en) | Composition and method for treatment of diabetes | |
IL223289A0 (en) | Treatment of type 2 diabetes | |
HK1169993A1 (en) | Hsl inhibitors useful in the treatment of diabetes hsl | |
EP2480246A4 (en) | Composition and method for treatment of diabetes | |
EP2389171A4 (en) | Use of pterosin compounds for treating diabetes and obesity | |
PL2397151T3 (en) | Treatment of vascular complications of diabetes | |
GB0908101D0 (en) | Treatment of stress | |
EP2437771A4 (en) | Compositions and methods modulating mg29 for the treatment of diabetes | |
EP2498794A4 (en) | Method of treatment of type 2 diabetes | |
GB0802903D0 (en) | Treatment of diabetes | |
GB0902157D0 (en) | Treatment of obesity | |
GB0813310D0 (en) | Treatment of obesity | |
ZA200907778B (en) | Method of treating diabetes | |
GB0904271D0 (en) | Treatment of diabetes and metabolic syndrome | |
GB0910904D0 (en) | Treatment of diabetes and metabolic syndrome | |
GB0912906D0 (en) | Treatment of diabetes and metabolic syndrome | |
AU2008901947A0 (en) | Treatment of Ores |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |